Astrana Health (FRA:3AM) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:3AM Astrana Health Inc FRA:3AM
81 GF Score
Price €31.40
GF Value €71.75
! 5 Warning Signs
View Full Analysis

What is Astrana Health FFO?

FFO (Funds from operations) only applies to REITs.

FRA:3AM
81GF Score
Astrana Health Inc FRA:3AM
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Astrana Health (FRA:3AM) Overvalued in 2026?

Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued. The current stock price of €31.40 is trading 56.2% below its estimated GF Value™ of €71.75.

Key valuation signals for FRA:3AM:

  • FFO:
  • GF Value™: €71.75 vs. price of €31.40 (56.2% below fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the FRA:3AM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Astrana Health Business Description

Other Exchanges ASTH:USA3AM:Germany
Address 1668 South Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
81GF Score

Get the complete analysis for FRA:3AM

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€31.40
Price
€71.75
GF Value